Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which anticipates that there will be a boom between 2010 and 2015 in the nanobiotechnology market.
Additionally, “Nanobiotechnology”
The report finds that is will be driven by an increasing use of nanobiotechnology by the pharmaceutical and biotechnology industries. Authors of the report say that nanotechnology will be applied at all stages of drug development - from formulations for optimal delivery to diagnostic applications in clinical trials.
The report states that the most important pharmaceutical applications of nanobiotechnology are in drug delivery. This field offers solutions to solubility problems, aids intracellular deliver possibility as well improve skin penetrations in transdermal drug delivery. In fact, a whole new field, Nanomedicine, is now within the realm of reality starting with nanodiagnostics and drug delivery facilitated by nanobiotechnology.
While there us still concern in the industry about the safety of nanoparticles introduced in to the human body and released into the environment, the study says research is underway to address these issues. It also expects that there will be clear FDA directives to regulate the market when these products are ready for use.
The report calculates future nanobiotechnology markets based on a comprehensive and thorough review of the current status of the market, research work in progress and anticipated progress.
It profiles 238 companies and their 147 collaborations.
“Nanobiotechnology”
http://www.piribo.com/
Piribo product ID: JAI025
